methylprednisolone has been researched along with Neurofibromatosis 1 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujimoto, M; Fujisawa, Y; Inoue, S; Ishitsuka, Y; Ogawa, T | 1 |
Bernard-Weil, E; Metzger, J; Pertuiset, B | 1 |
2 other study(ies) available for methylprednisolone and Neurofibromatosis 1
Article | Year |
---|---|
Neurofibromatosis type 1-associated serious haemorrhagic events successfully treated with steroid pulse therapy.
Topics: Aged; Anti-Inflammatory Agents; Female; Humans; Methylprednisolone; Neurofibromatosis 1; Shock, Hemorrhagic | 2018 |
[Hormonal (vasopressin-corticoid) treatment of 16 cases of inoperable cerebral tumors with little or no malignant potential].
Topics: Adrenocorticotropic Hormone; Adult; Aged; Astrocytoma; Brain Neoplasms; Cerebral Ventriculography; Craniopharyngioma; Echoencephalography; Electroencephalography; Female; Glucocorticoids; Humans; Male; Meningioma; Methylprednisolone; Middle Aged; Neurofibromatosis 1; Vasopressins; Visual Field Tests | 1973 |